期刊文献+

上皮源性卵巢癌中4种miRNAs的表达及其临床意义 被引量:13

Expression and clinical significance of four mi RNAs in epithelial ovarian cancer
下载PDF
导出
摘要 目的 分析上皮源性卵巢癌(EOC)组织中mi R-200a、mi R-141、mi R-205和mi R-34a的表达及其临床意义。方法 44例EOC患者按FIGO分期分为FIGOⅠ~Ⅱ(FIGO早期组)组15例和FIGOⅢ~Ⅳ(FIGO晚期组)组29例,用实时荧光定量PCR定量比较2组4种mi RNAs的表达差异并考察4种mi RNAs表达间的关联。以各组mi RNAs表达的中位数将EOC患者分为mi RNA高表达组和低表达组,比较2组患者间的生存差异。按年龄、FIGO分期、术后是否有残余瘤及术后化疗情况分组,进行Kaplan-Meier生存分析和Cox多因素分析。结果 FIGO晚期组mi R-141的表达高于早期组(P=0.036)。mi R-141的表达与mi R-200a、mi R-205呈正相关,与mi R-34a呈负相关(均P〈0.05);mi R-200a与mi R-205的表达呈正相关(P〈0.05)。生存分析显示,mi R-200a的表达低,卵巢癌患者无进展生存期短(P=0.035),FIGO早期组生存率高于FIGO晚期组(P〈0.05)。mi R-200a的表达水平、FIGO分期以及年龄与卵巢癌患者总生存期和无进展生存期有关,mi R-141、mi R-205和mi R-34a的表达水平、术后残余瘤以及化疗与患者生存无关。结论 mi R-200a的表达与卵巢癌患者预后有关,可能是卵巢癌患者预后预测的独立影响指标。 Objective To determine the expressions of miR-200a, miR-141, miR-205 and miR-34a in epithelial ovarian cancer (EOC) samples and to explore their clinical significance. Methods According to FIGO staging, 44 EOC patients were divided into two groups:early FIGO stage (stageⅠ-Ⅱ, n=15) and late FIGO stage (stageⅢ-Ⅳ, n=29). Expressions of 4 miRNAs were detected by real time quantitative PCR, and were compared between two groups. The correlation of 4 miRNAs was calculated. EOC patients were divided into high miRNA expression group and low expression group according to the median value of miRNAs expression. Kaplan-Meier survival analysis and Cox multivariate analysis were used to compare the age, FIGO state, tumor residual after operation and post-operative chemotherapy of ovarian cancer between two groups. Results The expression of miR-141 was elevated in stagesⅢandⅣcompared with that of stagesⅠand Ⅱ(P=0.036). There was a positive correlation between expression of miR-141, miR-200a and miR-205, but a negative correlation with miR-34a (P〈0.05). There was a positive correlation between miR-200a and miR-205 (P〈0.05). Lower miR-200a expression was associated with shorter progress free survival in ovarian cancer analyzed by log-rank test ( P=0.035). The survival rate was significantly higher in FIGO stages ⅠandⅡthan that of FIGO stagesⅢandⅣ(P〈0.05). Cox regression analysis revealed that miR-200a, FIGO stage and age were influential factors of overall survival time and progress-free survival time of ovarian cancer, while miR-141, miR-205, miR-34a and tumor residual after operation and post-operative chemotherapy were not influential factors. Conclusion The expression of miR-200a is closely correlated with the progress and prognosis of ovarian cancer and may be used as an independent indicator for ovarian cancer prognosis.
出处 《天津医药》 CAS 2015年第9期996-1000,共5页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(81072363)
关键词 微RNAS 卵巢肿瘤 上皮-间质转化 上皮源性 MI R-200a MI R-141 MI R-205 MI R-34a microRNAs ovarian neoplasms epithelial-mesenchymal transition epithelial miR-200a miR-141 miR-205 miR-34a
  • 相关文献

参考文献18

  • 1Siegel R, Naishadham D, Jemal A.Cancer statistics, 2013[J]. CA Cancer J C1in,2013,63(1):11-30. doi: 10.3322/caac.21166. 被引量:1
  • 2George EM, Herzog TJ, Neugut AI, et al. Carcinosarcoma of the ova- ry: natural history, patterns of treatment, and outcome[J]. Gynecol Oneol,2013,131(1):42-45. doi: 10.1016/j.ygyno.2013.06.034. 被引量:1
  • 3Chen W,Zheng R,Zhang S, et al.Annual report on status of cancer in China, 20100]. Chin J Cancer Res,2014,26(1):48-58. doi: 10.3978/ j.issn. 1000-9604.2014.01.08. 被引量:1
  • 4Lee S,Yang Y,Fishman D, et al.Epithelial-mesenchymal transition enhances nanoscale actin filament dynamics of ovarian cancer cells[J]. J Phys Chem B,2013,117(31 ):9233 -9240. doi: 10.1021/jp4055186. 被引量:1
  • 5Yang D,Sun Y,Hu L, et al.Integrated analyses identify a master mi- croRNA regulatory network for the mesenchymal subtype in serous ovarian eancer[J].Cancer Ce11,2013,23(2):186- 199. doi: 10.1016/j. cer.2012.12.020. 被引量:1
  • 6Zheng H,Zhang L,Zhao Y, et al.Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer[J].PloS One,2013,8(I1): e77853, doi: 10.1371/journal.pone.0077853. 被引量:1
  • 7Barrel DP.MicroRNAs: target recognition and regulatory functions [J].Cell,2009,136(2):215-233. doi: lO.1016/j.cell.2009.01,002. 被引量:1
  • 8Guo F,Parker Kerrigan BC,Yang D, et al.Post-transcriptional regu- latory network of epithelial-to-mesenchymal and mesenchymal-to- epithelial transitions[J]. J Hematol Oneol,2014,7:19. doi: 10.1186/ 1756-8722-7-19. 被引量:1
  • 9Park SM,Gaur AB,Lengyel E, et al.The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2[J]. Genes Dev,2008,22(7):894-907. doi: 10.1101/~ad.1640608. 被引量:1
  • 10Dykxhoorn DM.MicroRNAs and metastasis: little RNAs go a long way[J]. Cancer Res,2010,70(16):6go1- 6406. doi: 10.1158/0008- 5472.CAN-10-1346. 被引量:1

同被引文献80

引证文献13

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部